Role of patelet-activating factor in pathogenesis of acute pancreatitis

World Journal of Gastroenterology

Volumn 12, Issue 4, 2006, Pages 539-545

  Liu, Li Rong ^a   Xia, Shi Hai ^a  

^a MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

Pancreatis; Pathogenesis; Platelet activating factor; Signal transduction

Indexed keywords

2 [N (2 METHOXY 3 OCTADECYLCARBAMOYLOXYPROPOXYCARBONYL)ACETAMIDOMETHYL] 1 ETHYLPYRIDINIUM CHLORIDE; 3 BROMO 5 [N PHENYL N [2 [[2 (1,2,3,4 TETRAHYDRO 2 ISOQUINOLYLCARBONYLOXY)ETHYL]CARBAMOYL]ETHYL]CARBAMOYL] 1 PROPYLPYRIDINIUM NITRATE; BEPAFANT; G PROTEIN COUPLED RECEPTOR; GINKGOLIDE B; GLYCEROPHOSPHOLIPID; LEXIPAFANT; PANCREAS ENZYME; PHOSPHOLIPID; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ACUTE PANCREATITIS; ANGIOGENESIS; APOPTOSIS; CELL TYPE; CHEMOTAXIS; DISEASE ASSOCIATION; ENZYME ACTIVATION; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LONG TERM POTENTIATION; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RECEPTOR BINDING; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION; WOUND HEALING; ACUTE DISEASE; ANIMAL; BACTERIAL TRANSLOCATION; DRUG ANTAGONISM; INTESTINE; LEUKOCYTE; METABOLISM; MICROCIRCULATION; PANCREATITIS; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ACUTE DISEASE; ANIMALS; APOPTOSIS; BACTERIAL TRANSLOCATION; ENDOTHELIUM, VASCULAR; HUMANS; INTESTINES; LEUKOCYTES; MICROCIRCULATION; PANCREATITIS; PLATELET ACTIVATING FACTOR;

EID: 33644900466     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i4.539     Document Type: Review

References (71)

1. Emanuelli G, Montrucchio G, Gaia E, Dughera L, Corvetti G, Gubetta L. Experimental acute pancreatitis induced by platelet activating factor in rabbits. Am J Pathol 1989; 134: 315-326
2. Zhou W, Levine BA, Olson MS. Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation. Am J Pathol 1993; 142: 1504-1512
3. Flickinger BD, Olson MS. Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells. Am J Pathol 1999; 154: 1353-1358
4. Benveniste J, Henson PM, Cochrane CG. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med 1972; 136: 1356-1377
5. Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM. Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 2003; 40: 643-672
6. Honda Z, Ishii S, Shimizu T. Platelet-activating factor receptor. J Biochem (Tokyo) 2002; 131: 773-779
7. Blank ML, Snyder F, Byers LW, Brooks B, Muirhead EE. Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochem Biophys Res Commun 1979; 90: 1194-1200
8. Demopoulos CA, Pinckard RN, Hanahan DJ. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem 1979; 254: 9355-9358
9. Benveniste J, Tence M, Varenne P, Bidault J, Boullet C, Polonsky J. Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine. C R Seances Acad Sci D 1979; 289: 1037-1040
10. Ninio E, Mencia-Huerta JM, Heymans F, Benveniste J. Biosynthesis of platelet-activating factor. I. Evidence for an acetyl-transferase activity in murine macrophages. Biochim Biophys Acta 1982; 710: 23-31
11. Francescangeli E, Domanska-Janik K, Goracci G. Relative contribution of the de novo and remodelling pathways to the synthesis of platelet-activating factor in brain areas and during ischemia. J Lipid Mediat Cell Signal 1996; 14: 89-98
12. Arai H. Platelet-activating factor acetylhydrolase. Prostaglandins Other Lipid Mediat 2002; 68-69: 83-94
13. Ishii S, Shimizu T. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res 2000; 39: 41-82
14. Hikiji H, Ishii S, Shindou H, Takato T, Shimizu T. Absence of platelet-activating factor receptor protects mice from osteoporosis following ovariectomy. J Clin Invest 2004; 114: 85-93
15. Denizot Y, Donnard M, Guglielmi L, Faucher JL, Jaccard A, Bordessoule D, Trimoreau F. Detection of functional platelet-activating factor receptors on leukemic B cells of chronic lymphocytic leukemic patients. Leuk Lymphoma 2004; 45: 515-518
16. Ramos G, Kazimi N, Nghiem DX, Walterscheid JP, Ullrich SE. Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression. Toxicol Appl Pharmacol 2004; 195: 331-338
17. Du YM, Tang M, Liu CJ, Ke QM, Luo HY, Hu XW. Effects of platelet activating factor on action potentials and potassium channels in guinea-pig ventricular myocytes. Shengli Xuebao 2004; 56: 282-287
18. Yoshida H, Imaizumi T, Tanji K, Sakaki H, Metoki N, Hatakeyama M, Yamashita K, Ishikawa A, Taima K, Sato Y, Kimura H, Satoh K. Platelet-activating factor enhances the expression of nerve growth factor in normal human astrocytes under hypoxia. Brain Res Mol Brain Res 2005; 133: 95-101
19. Ersoy B, Huseyinov A, Darcan S. The role of platelet-activating factor in pathogenesis of type 1 diabetes. Diabetes Care 2005; 28: 980
20. Grypioti AD, Theocharis SE, Papadimas GK, Demopoulos CA, Papadopoulou-Daifoti Z, Basayiannis AC, Mykoniatis MG. Platelet-activating factor (PAF) involvement in acetaminophen-induced liver toxicity and regeneration. Arch Toxicol 2005; 79: 466-474
21. Chao W, Olson MS. Platelet-activating factor: receptors and signal transduction. Biochem J 1993; 292 (Pt 3): 617-629
22. Izumi T, Shimizu T. Platelet-activating factor receptor: gene expression and signal transduction. Biochim Biophys Acta 1995; 1259: 317-333
23. Shimizu T, Mori M, Bito H, Sakanaka C, Tabuchi S, Aihara M, Kume K. Platelet-activating factor and somatostatin activate mitogen-activated protein kinase (MAP kinase) and arachidonate release. J Lipid Mediat Cell Signal 1996; 14: 103-108
24. Coffer PJ, Geijsen N, M'rabet L, Schweizer RC, Maikoe T, Raaijmakers JA, Lammers JW, Koenderman L. Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function. Biochem J 1998; 329 (Pt 1): 121-130
25. Marques SA, Dy LC, Southall MD, Yi Q, Smietana E, Kapur R, Marques M, Travers JB, Spandau DF. The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway. J Pharmacol Exp Ther 2002; 300: 1026-1035
26. Chen LW,. Lin MW, Hsu CM. Different pathways leading to activation of extracellular signal-regulated kinase and p38 MAP kinase by formyl-methionyl-leucyl-phenylalanine or platelet activating factor in human neutrophils. J Biomed Sci 2005; 12: 311-319
27. Nick JA, Avdi NJ, Young SK, Knall C, Gerwins P, Johnson GL, Worthen GS. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J Clin Invest 1997; 99: 975-986
28. DeCoster MA, Mukherjee PK, Davis RJ, Bazan NG. Platelet-activating factor is a downstream messenger of kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons. J Neurosci Res 1998; 53: 297-303
29. Deo DD, Bazan NG, Hunt JD. Activation of platelet-activating factor receptor-coupled G alpha q leads to stimulation of Src and focal adhesion kinase via two separate pathways in human umbilical vein endothelial cells. J Biol Chem 2004; 279: 3497-3508
30. Ye RD, Kravchenko VV, Pan Z, Feng L. Stimulation of NF-kappa B activation and gene expression by platelet-activating factor. Adv Exp Med Biol 1996; 416: 143-151
31. Schulam PG, Kuruvilla A, Putcha G, Mangus L, Franklin-Johnson J, Shearer WT. Platelet-activating factor induces phospholipid turnover, calcium flux, arachidonic acid liberation, eicosanoid generation, and oncogene expression in a human B cell line. J Immunol 1991; 146: 1642-1648
32. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol 1988; 3: 105-112
33. Lundberg AH, Eubanks JW 3rd, Henry J, Sabek O, Kotb M, Gaber L, Norby-Teglund A, Gaber AO. Trypsin stimulates production of cytokines from peritoneal macrophages in vitro and in vivo. Pancreas 2000; 21: 41-51
34. Zhao H, Chen JW, Zhou YK, Zhou XF, Li PY. Influence of platelet activating factor on expression of adhesion molecules in experimental pancreatitis. World J Gastroenterol 2003; 9: 338-341
35. Desouza IA, Hyslop S, Franco-Penteado CF, Ribeiro-DaSilva G. Evidence for the involvement of a macrophage-derived chemotactic mediator in the neutrophil recruitment induced by staphylococcal enterotoxin B in mice. Toxicon 2002; 40: 1709-1717
36. Au BT, Teixeira MM, Collins PD, Williams TJ. Blockade of PAF receptors controls interleukin-8 production by regulating the activation of neutrophil CD11/CD18. Eur J Pharmacol 2001; 425: 65-71
37. Schwartz JD, Shamamian P, Grossi EA, Schwartz DS, Marcus SG, Steiner F, Jacobs CE, Tayyarah M, Eng K, Colvin SB, Galloway AC. Lexipafant inhibits platelet activating factor enhanced neutrophil functions. J Surg Res 1997; 69: 240-248
38. Guan Z, Li Y, Wang S, Yang J. Role of interleukin-6 and platelet-activating factor in delaying neutrophil apoptosis. Weisheng Yanjiu 2000; 29: 131-133
39. Khreiss T, Jozsef L, Chan JS, Filep JG. Activation of extracellular signal-regulated kinase couples platelet-activating factor-induced adhesion and delayed apoptosis of human neutrophils. Cell Signal 2004; 16: 801-810
40. Kravchenko VV, Pan Z, Han J, Herbert JM, Ulevitch RJ, Ye RD. Platelet activating factor induces NF- kappa B activation through a G protein-coupled pathway. J Biol Chem 1995; 270: 14928-14934
41. Chen X, Ji B, Han B, Ernst SA, Simeone D, Logsdon CD. NF-kappaB activation in pancreas induces pancreatic and systemic inflammatory response. Gastroenterology 2002; 122: 448-457
42. Kusterer K, Poschmann T, Friedemann A, Enghofer M, Zendler S, Usadel KH. Arterial constriction, ischemia-reperfusion, and leukocyte adherence in acute pancreatitis. Am J Physiol 1993; 265: G165-G171
43. Sugimoto M, Takada T, Yasuda H. A new experimental pancreatitis by incomplete closed duodenal loop: the influence of pancreatic microcirculation on the development and progression of induced severe pancreatitis in rats. Pancreas 2004; 28: e112-e119
44. Montrucchio G, Lupia E, De Martino A, Silvestro L, Savu SR, Cacace G, De Filippi PG, Emanuelli G, Camussi G. Plasmin promotes an endothelium-dependent adhesion of neutrophils. Involvement of platelet activating factor and P-selectin. Circulation 1996; 93: 2152-2160
45. Victorino GP, Newton CR, Curran B. Modulation of microvascular hydraulic permeability by platelet-activating factor. J Trauma 2004; 56: 379-384
46. Foitzik T, Hotz HG, Eibl G, Hotz B, Kirchengast M, Buhr HJ. Therapy for microcirculatory disorders in severe acute pancreatitis: effectiveness of platelet-activating factor receptor blockade vs. endothelin receptor blockade. J Gastrointest Surg 1999; 3: 244-251
47. Eibl G, Buhr HJ, Foitzik T. Therapy of microcirculatory disorders in severe acute pancreatitis: what mediators should we block? Intensive Care Med 2002; 28: 139-146
48. Kazantsev GB, Hecht DW, Rao R, Fedorak IJ, Gattuso P, Thompson K, Djuricin G, Prinz RA. Plasmid labeling confirms bacterial translocation in pancreatitis. Am J Surg 1994; 167: 201-206; discussion 206-207
49. Sun XM, Qu XW, Huang W, Granger DN, Bree M, Hsueh W. Role of leukocyte beta 2-integrin in PAF-induced shock and intestinal injury. Am J Physiol 1996; 270: G184-G190
50. Qu XW, Rozenfeld RA, Huang W, Bulkley GB, Hsueh W. The role of xanthine oxidase in platelet-activating factor-induced intestinal injury in the rat. Gut 1999; 44: 203-211
51. Tan XD, Chang H, Qu XW, Caplan M, Gonzalez-Crussi F, Hsueh W. Platelet-activating factor increases mucosal permeability in rat intestine via tyrosine phosphorylation of E-cadherin. Br J Pharmacol 2000; 129: 1522-1529
52. Andersson R, Wang X, Sun Z, Deng X, Soltesz V, Ihse I. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats. Pancreas 1998; 17: 107-119
53. Leveau P, Wang X, Sun Z, Borjesson A, Andersson E, Andersson R. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant. Biochem Pharmacol 2005; 69: 1325-1331
54. Zhu W, Li J, Tu W, Li N. Effects of platelet activating factor antagonist (BN50739) on gut mucosal injury in acute severe pancreatitis in pigs. Chin Med J (Engl) 2000; 113: 756-758
55. de Souza LJ, Sampietre SN, Assis RS, Knowles CH, Leite KR, Jancar S, Monteiro Cunha JE, Machado MC. Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis. J Gastrointest Surg 2001; 5: 364-370
56. Bedirli A, Gokahmetoglu S, Sakrak O, Soyuer I, Ince O, Sozuer E. Beneficial effects of recombinant platelet-activating factor acetylhydrolase and BN 52021 on bacterial translocation in cerulein-induced pancreatitis. Eur Surg Res 2004; 36: 136-141
57. Kaiser AM, Saluja AK, Sengupta A, Saluja M, Steer ML. Relationship between severity, necrosis, and apoptosis in five models of experimental acute pancreatitis. Am J Physiol 1995; 269: C1295-C1304
58. Frossard JL, Rubbia-Brandt L, Wallig MA, Benathan M, Ott T, Morel P, Hadengue A, Suter S, Willecke K, Chanson M. Severe acute pancreatitis and reduced acinar cell apoptosis in the exocrine pancreas of mice deficient for the Cx32 gene. Gastroenterology 2003; 124: 481-493
59. Sandoval D, Gukovskaya A, Reavey P, Gukovsky S, Sisk A, Braquet P, Pandol SJ, Poucell-Hatton S. The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. Gastroenterology 1996; 111: 1081-1091
60. Dabrowski A, Gabryelewicz A, Chyczewski L. The effect of platelet activating factor antagonist (BN 52021) on cerulein-induced acute pancreatitis with reference to oxygen radicals. Int J Pancreatol 1991; 8: 1-11
61. Jancar S, Abdo EE, Sampietre SN, Kwasniewski FH, Coelho AM, Bonizzia A, Machado MC. Effect of PAF antagonists on cerulein-induced pancreatitis. J Lipid Mediat Cell Signal 1995; 11: 41-49
62. Ji Z, Wang B, Li S. The role of platelet activating factor in mesenterioangial microcirculatory disturbance complicated with acute pancreatitis in rats. Zhonghua Yixue Zazhi 1995; 75: 139-140, 188
63. Dabrowski A, Gabryelewicz A, Chyczewski L. The effect of platelet activating factor antagonist (BN 52021) on acute experimental pancreatitis with reference to multiorgan oxidative stress. Int J Pancreatol 1995; 17: 173-180
64. Wereszczynska-Siemiatkowska U, Dlugosz JW, Siemiatkowski A, Chyczewski L, Gabryelewicz A. Lysosomal activity of pulmonary alveolar macrophages in acute experimental pancreatitis in rats with reference to positive PAF-antagonist (BN 52021) effect. Exp Toxicol Pathol 2000; 52: 119-125
65. Tu W, Li J, Zhu W. Influences of BN50739 on neutrophil elastase and phospholipase A2 in lung and tracheal mucosa of pigs with acute severe pancreatitis. Zhonghua Jiehe He Huxi Zazhi 2000; 23: 595-598
66. Wang X, Sun Z, Borjesson A, Haraldsen P, Aldman M, Deng X, Leveau P, Andersson R. Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis. Int J Pancreatol 1999; 25: 45-52
67. Wang X, Sun Z, Borjesson A, Andersson R. Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction. Br J Surg 1999; 86: 411-416
68. Lane JS, Todd KE, Gloor B, Chandler CF, Kau AW, Ashley SW, Reber HA, McFadden DW. Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis. J Surg Res 2001; 99: 365-370
69. Liu Q, Djuricin G, Rossi H, Bewsey K, Nathan C, Gattuso P, Weinstein RA, Prinz RA. The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats. Am Surg 1999; 65: 611-616; discussion 617
70. Tomaszewska R, Dembinski A, Warzecha Z, Banas M, Konturek SJ, Stachura J. Platelet activating factor (PAF) inhibitor (TCV-309) reduces caerulein- and PAF-induced pancreatitis. A morphologic and functional study in the rat. J Physiol Pharmacol 1992; 43: 345-352
71. Yamaguchi Y, Matsumura F, Liang J, Okabe K, Matsuda T, Ohshiro H, Ishihara K, Akizuki E, Yamada S, Ogawa M. Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats. Pancreas 1999; 18: 355-363